Gary E. Gallick - Concepedia

Author

Gary E. Gallick

The University of Texas MD Anderson Cancer Center

Also Known As

Christopher G Wood, Christopher J. Logothetis, Eric Jonasch, Francis Ali-Osman, G E Gallick, G Gallick, G. E. Gallick, G. Gallick, G.E. Gallick, Gary E Gallick

445

Publications

17.7K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Spanish Oncology Genitourinary Group Baylor College of Medicine The University of Texas Health Science Center at Houston Anderson Hospital

About

Gary E. Gallick is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, tumor biology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	49	80	8.3K
2	Cell Biology	45	59	7.3K
3	Natural Sciences	7	7	286
4	Health Sciences	6	6	1.1K
5	Biochemistry	2	2	31

Gary E. Gallick

164

Publications

15.9K

Citations

H-Index

Page 1

	Year	Citations
Epithelial to Mesenchymal Transition Contributes to Drug Resistance in Pancreatic Cancer Thiruvengadam Arumugam, Vijaya Ramachandran, Keith F. Fournier, Cancer Research Pancreatic CancerHealth SciencesMedicineMesenchymal Transition ContributesPathology	2009	856
BCR-ABL independence and LYN kinase overexpression in chronic myelogenous leukemia cells selected for resistance to STI571 Nicholas J. Donato, Ji Yuan Wu, Jonathan Stapley, Blood	2002	662
Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway Zhiwei Wang, Yiwei Li, Dejuan Kong, Cancer Research	2009	618
Development and Characterization of Gemcitabine-Resistant Pancreatic Tumor Cells Ami N. Shah, Justin M. Summy, Jing Zhang, Annals of Surgical Oncology Pancreatic CancerMedicineCell BiologyCancer ResearchTumor Biology	2007	431
Increase in activity and level of pp60c-src in progressive stages of human colorectal cancer. Mark S. Talamonti, Mark S. Roh, S. Curley, Journal of Clinical Investigation Tyrosine KinaseGastroenterologyPathologyCancer BiologyTumor Biology	1993	397
Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice Michael P. Kim, Douglas B. Evans, Huamin Wang, Nature Protocols Tumor BiologyXenotransplantationPancreatic CancerOncogenic AgentMedicine	2009	381
HIF-1α, STAT3, CBP/p300 and Ref-1/APE are components of a transcriptional complex that regulates Src-dependent hypoxia-induced expression of VEGF in pancreatic and prostate carcinomas Michael J. Gray, Jing Zhang, Lee M. Ellis, Oncogene Transcriptional RegulationSrc-dependent Hypoxia-induced ExpressionMedicineHypoxia (Medicine)Cancer Cell Biology	2005	370
EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells Young Do Jung, Min-Gyun Kim, B A Shin, British Journal of Cancer	2001	327
A ROR1–HER3–lncRNA signalling axis modulates the Hippo–YAP pathway to regulate bone metastasis Chunlai Li, Shouyu Wang, Zhen Xing, Nature Cell Biology Developmental BiologyBone Morphogenic ProteinMedicineHippo–yap PathwayBone Homeostasis	2017	315
ALDH Activity Selectively Defines an Enhanced Tumor-Initiating Cell Population Relative to CD133 Expression in Human Pancreatic Adenocarcinoma Michael P. Kim, Jason B. Fleming, Huamin Wang, PLoS ONE	2011	299

Page 1